A detailed history of Fin Trust Capital Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Fin Trust Capital Advisors, LLC holds 9,445 shares of JNJ stock, worth $1.48 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
9,445
Previous 8,864 6.55%
Holding current value
$1.48 Million
Previous $1.3 Million 18.15%
% of portfolio
0.27%
Previous 0.25%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$145.48 - $167.38 $84,523 - $97,247
581 Added 6.55%
9,445 $1.53 Million
Q2 2024

Jul 24, 2024

BUY
$144.38 - $157.78 $43,602 - $47,649
302 Added 3.53%
8,864 $1.3 Million
Q1 2024

May 02, 2024

BUY
$155.22 - $162.74 $236,089 - $247,527
1,521 Added 21.6%
8,562 $1.35 Million
Q4 2023

Feb 13, 2024

SELL
$145.6 - $158.88 $121,139 - $132,188
-832 Reduced 10.57%
7,041 $1.1 Million
Q3 2023

Oct 24, 2023

SELL
$155.75 - $174.48 $268,980 - $301,326
-1,727 Reduced 17.99%
7,873 $1.23 Million
Q4 2022

Feb 14, 2023

SELL
$160.2 - $179.79 $29,476 - $33,081
-184 Reduced 1.88%
9,600 $1.7 Million
Q3 2022

Oct 20, 2022

SELL
$161.33 - $179.52 $35,169 - $39,135
-218 Reduced 2.18%
9,784 $1.62 Million
Q2 2022

Jul 26, 2022

SELL
$168.19 - $186.01 $273,476 - $302,452
-1,626 Reduced 13.98%
10,002 $1.72 Million
Q1 2022

May 03, 2022

SELL
$158.14 - $179.59 $16,762 - $19,036
-106 Reduced 0.9%
11,628 $2.06 Million
Q4 2021

Feb 14, 2022

BUY
$155.93 - $173.01 $49,429 - $54,844
317 Added 2.78%
11,734 $2.01 Million
Q3 2021

Nov 16, 2021

SELL
$161.5 - $179.47 $24,386 - $27,099
-151 Reduced 1.31%
11,417 $1.84 Million
Q2 2021

Aug 16, 2021

SELL
$159.48 - $171.07 $89,787 - $96,312
-563 Reduced 4.64%
11,568 $1.91 Million
Q1 2021

May 17, 2021

BUY
$153.07 - $170.48 $64,595 - $71,942
422 Added 3.6%
12,131 $1.99 Million
Q4 2020

Feb 16, 2021

BUY
$137.11 - $157.38 $81,580 - $93,641
595 Added 5.35%
11,709 $1.84 Million
Q3 2020

Nov 10, 2020

BUY
$140.38 - $153.83 $887,341 - $972,359
6,321 Added 131.88%
11,114 $1.66 Million
Q2 2020

Sep 11, 2020

BUY
$128.81 - $155.51 $617,386 - $745,359
4,793 New
4,793 $674,000
Q2 2020

Aug 14, 2020

SELL
$128.81 - $155.51 $653,453 - $788,902
-5,073 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$111.14 - $153.99 $161,375 - $223,593
-1,452 Reduced 22.25%
5,073 $665,000
Q4 2019

Jan 23, 2020

SELL
$127.5 - $146.44 $84,277 - $96,796
-661 Reduced 9.2%
6,525 $952,000
Q3 2019

Oct 29, 2019

SELL
$126.95 - $142.14 $64,363 - $72,064
-507 Reduced 6.59%
7,186 $930,000
Q2 2019

Aug 01, 2019

SELL
$131.15 - $144.24 $201,971 - $222,129
-1,540 Reduced 16.68%
7,693 $1.07 Million
Q1 2019

May 09, 2019

SELL
$125.72 - $139.79 $32,812 - $36,485
-261 Reduced 2.75%
9,233 $1.29 Million
Q4 2018

Feb 11, 2019

BUY
$122.84 - $147.84 $1.17 Million - $1.4 Million
9,494 New
9,494 $1.23 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $410B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Fin Trust Capital Advisors, LLC Portfolio

Follow Fin Trust Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.